VAERS reports by lot

Pfizer COVID-19 lot EW1050: VAERS reports

24 VAERS reports list lot EW1050 as a Pfizer COVID-19 vaccine, received between 2021-04-05 and 2023-03-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
25%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular2120%
Gastrointestinal1817%
Neurological1615%
General / Systemic (non-local)1615%
Respiratory1110%
Allergic / Anaphylactic77%
Psychiatric / Neuropsychiatric66%
Dermatological (non-injection-site)55%
Musculoskeletal33%
Injection-site / Local reaction33%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Michigan3
Idaho2
Illinois1
Georgia1
Indiana1
Louisiana1
Texas1
South Carolina1
New Hampshire1
Wisconsin1
Minnesota1

Reports by month received

2021-0411
2021-052
2021-071
2021-083
2021-092
2021-101
2022-012
2022-021
2023-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.